Contributions are welcome. These will be scheduled after acceptence either in a limited number of contributed talks (15 min + 5 min discussion) or posters. Please indicate your preference.
Please send a title and an abstract of your contribution using the subject "Int. Conf on Dermal Drug Delivery by Nanocarriers: YOUR Name" to: conference (at) sfb1112.de
Please use the Abstract Template, which must be sent as a doc.-/docx.- or rtf.-file.
Abstract format in brief: Times New Roman, 12 pt, double spaced, 2.5 cm margins on all sides, max. 1 page; content: title, author name(s), institutional address(es), text to be communicated, and references. Submitted abstracts will be evaluated by the Scientific Committee of SFB 1112 and contributors will be notified upon acceptance.
Please prepare your poster in DIN A0 (max: 841 mm width x 1189 mm height), upright format ("Portrait").
Please bring your poster with you and hang it up yourself, right at the beginning of the conference. The numbered poster boards will be set up in the ground floor seminar room and in the second floor foyer of Zuse-Zentrum Berlin. For your poster number, please see the list of poster contributions.
Poster contributions will be presented in two poster sessions: Poster Session 1 on Monday evening, Poster Session 2 on Tuesday during the lunch break.
All poster contributions have been attributed with a number (see above). We want to ask all poster authors to present their work as follows:
Poster Session 1:
Monday March 14. 2016, 6:00 - 8:00 pm / 18:00 - 20:00 h
Poster contributions with even numbers
Poster Session 2:
Tuesday, March 15, 2016, 12:45 am - 2:45 pm / 12:45 - 14:45 h
Poster contributions with odd numbers
The Poster Prizes will be awarded on Tuesday evening in the frame of the Conference Dinner.
Proceedings of the SFB 1112 Conference Contributions will be published as a pdf-file, which can be downloaded via the Conference-Website here (password protected).
Special Issues of Journal of Controlled Release and European Journal of Pharmaceutics and Biopharmaceutics covering selected conference contributions are planned.
More details will be announced soon.